Welcome, Guest. Please login or register.
November 22, 2017, 09:24:42 PM

Login with username, password and session length

  • Total Posts: 722671
  • Total Topics: 58734
  • Online Today: 342
  • Online Ever: 1421
  • (August 13, 2016, 05:18:44 AM)
Users Online


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: U.S.: do not mix Merck hepatitis pill with HIV drugs  (Read 1781 times)

0 Members and 1 Guest are viewing this topic.

Offline ichigo_kun

  • Member
  • Posts: 49
U.S.: do not mix Merck hepatitis pill with HIV drugs
« on: April 26, 2012, 12:44:37 PM »
WASHINGTON (Reuters) - U.S. drug regulators are changing the label for Merck & Co Inc's recently approved Victrelis treatment for hepatitis C to show it should not be taken with some widely used HIV medicines.

"Co-administration (of the two drugs) ... is not recommended at this time because of the possibility of reducing the effectiveness of the medicines, permitting the amount of HCV (hepatitis C virus) or HIV ... in the blood to increase," the U.S. Food and Drug Administration said on Thursday.

The FDA and Merck first warned about the issue in February based on the results of a drug interaction study, but a label change could further crimp sales of Victrelis.

Victrelis, approved last May, attacks the hepatitis C virus that over time can lead to chronic liver disease or liver failure. Many patients with hepatitis are also infected with the human immunodeficiency virus, or HIV, which weakens the immune system and is fatal without treatment.

The drug interaction study tested healthy volunteers who took Victrelis and the widely used HIV treatment Norvir (ritonavir) with one of three other anti-HIV pills. All of the HIV drugs work by blocking protease, an enzyme the virus needs in order to replicate.

The study found Victrelis reduced the concentrations of the HIV drugs in the blood.

Analysts have said the findings could crimp sales of Victrelis by as much as a quarter, since so many people are infected with both diseases.

The FDA said it is changing the label for Victrelis also based on a small clinical trial presented last month that studied a total of 98 people.

The trial results were not as conclusive as the drug interaction study. The trial tested people with both HIV and the hepatitis C virus, and gave some people Victrelis plus an older combination hepatitis C therapy, and others only the older combination treatment (peginterferon/ribavirin). All patients were given a type of anti-HIV pill.

Out of the 64 people taking Victrelis, three had a rebound in their HIV, while four of the 34 people taking only the older combo drug had a rebound of the virus.

Merck has said it still plans a larger drug-interaction trial of Victrelis with other HIV drugs.

The FDA said it would communicate any new information about taking Victrelis together with the HIV drugs when it becomes available.


Terms of Membership for these forums

© 2017 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.